Abattis Bioceuticals Corp. (ATTBF)

Market Cap	476.00 -96.3%
Revenue (ttm)	269.58K +4,163.2%
Net Income	-2.30M
EPS	-0.00
Shares Out	476.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,481
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.000001 - 0.0001
Beta	-45.19
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Abattis Bioceuticals

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 201...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATTBF

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 25, 2026

Data Sources Report a data error